144 related articles for article (PubMed ID: 38454810)
1. The role and molecular mechanism of NOP16 in the pathogenesis of nasopharyngeal carcinoma.
Xiong W; Li D; Ao F; Tu Z; Xiong J
Cell Biochem Funct; 2024 Mar; 42(2):e3939. PubMed ID: 38454810
[TBL] [Abstract][Full Text] [Related]
2. FOXD3 inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma through regulation of the PI3K-Akt pathway.
Xie X; Xiong G; Chen W; Fu H; Li M; Cui X
Biochem Cell Biol; 2020 Dec; 98(6):653-660. PubMed ID: 32459973
[TBL] [Abstract][Full Text] [Related]
3. C2orf40 inhibits metastasis and regulates chemo-resistance and radio-resistance of nasopharyngeal carcinoma cells by influencing cell cycle and activating the PI3K/AKT/mTOR signaling pathway.
Xie Z; Li W; Ai J; Xie J; Zhang X
J Transl Med; 2022 Jun; 20(1):264. PubMed ID: 35676661
[TBL] [Abstract][Full Text] [Related]
4. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
Zuo WN; Zhu H; Li LP; Jin AY; Wang HQ
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7935-7942. PubMed ID: 31599418
[TBL] [Abstract][Full Text] [Related]
5. Saucerneol attenuates nasopharyngeal carcinoma cells proliferation and metastasis through selectively targeting Grp94.
Cheng Y; Wang Q; Zhang Z; Zhao C; Zhou H; Xu J; Gu Q
Phytomedicine; 2022 Jul; 101():154133. PubMed ID: 35504052
[TBL] [Abstract][Full Text] [Related]
6. Circ_0000523 regulates miR-1184/COL1A1/PI3K/Akt pathway to promote nasopharyngeal carcinoma progression.
Huang P; Li M; Tang Q; Jiang K; Luo Y
Apoptosis; 2022 Oct; 27(9-10):751-761. PubMed ID: 35759163
[TBL] [Abstract][Full Text] [Related]
7. Targeting Glutamine Metabolism through Glutaminase Inhibition Suppresses Cell Proliferation and Progression in Nasopharyngeal Carcinoma.
Su C; Li M; Yang Y; Wang Z; Wang Q; Wang W; Ma X; Jie R; Chen H; Li X; Lu J
Anticancer Agents Med Chem; 2023; 23(17):1944-1957. PubMed ID: 37497684
[TBL] [Abstract][Full Text] [Related]
8. LncRNA ZFAS1 promotes proliferation and migration and inhibits apoptosis in nasopharyngeal carcinoma via the PI3K/AKT pathway in vitro.
Wang X; Jin Q; Wang X; Chen W; Cai Z
Cancer Biomark; 2019; 26(2):171-182. PubMed ID: 31403940
[TBL] [Abstract][Full Text] [Related]
9. Nasopharyngeal carcinoma with non-squamous phenotype may be a variant of nasopharyngeal squamous cell carcinoma after inhibition of EGFR/PI3K/AKT/mTOR pathway.
Wang J; Shang Y; Wang Y; Li Y; Wang L; Huang S; Lyu X
Histol Histopathol; 2024 May; 39(5):647-657. PubMed ID: 37971211
[TBL] [Abstract][Full Text] [Related]
10. Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.
Feng B; Chen K; Zhang W; Zheng Q; He Y
J Clin Lab Anal; 2022 Dec; 36(12):e24720. PubMed ID: 36347827
[TBL] [Abstract][Full Text] [Related]
11. Function of AXL and molecular mechanisms in regulation of nasopharyngeal carcinoma.
Zhou K; Zhao J; Xu H; Yan X; Liu W; Jiang X; Ren C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 47(6):685-697. PubMed ID: 35837768
[TBL] [Abstract][Full Text] [Related]
12. APLNR is involved in ATRA-induced growth inhibition of nasopharyngeal carcinoma and may suppress EMT through PI3K-Akt-mTOR signaling.
Liu Y; Liu Q; Chen S; Liu Y; Huang Y; Chen P; Li X; Gao G; Xu K; Fan S; Zeng Z; Xiong W; Tan M; Li G; Zhang W
FASEB J; 2019 Nov; 33(11):11959-11972. PubMed ID: 31408612
[TBL] [Abstract][Full Text] [Related]
13. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
[TBL] [Abstract][Full Text] [Related]
14. miR-331-3p Inhibits Proliferation and Promotes Apoptosis of Nasopharyngeal Carcinoma Cells by Targeting elf4B-PI3K-AKT Pathway.
Xuefang Z; Ruinian Z; Liji J; Chun Z; Qiaolan Z; Jun J; Yuming C; Junrong H
Technol Cancer Res Treat; 2020; 19():1533033819892251. PubMed ID: 31984860
[TBL] [Abstract][Full Text] [Related]
15. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-192 promotes the development of nasopharyngeal carcinoma through targeting RB1 and activating PI3K/AKT pathway.
Huang Q; Hou S; Zhu X; Liu S
World J Surg Oncol; 2020 Feb; 18(1):29. PubMed ID: 32013999
[TBL] [Abstract][Full Text] [Related]
17. ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling.
Pan S; Liang S; Wang X
Life Sci; 2021 Aug; 278():119581. PubMed ID: 33961854
[TBL] [Abstract][Full Text] [Related]
18. Chloroform extract from Sophora Tonkinensis Gagnep. inhibit proliferation, migration, invasion and promote apoptosis of nasopharyngeal carcinoma cells by silencing the PI3K/AKT/mTOR signaling pathway.
ShuoWang ; Song Z; Gong X; Ou C; Zhang W; Wang J; Yao C; Qin S; Yan B; Li Q; Wei K; Hou X; Zhou X; Miao J
J Ethnopharmacol; 2021 May; 271():113879. PubMed ID: 33524509
[TBL] [Abstract][Full Text] [Related]
19. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
Song L; Chen L; Luan Q; Kong Q
J Cell Physiol; 2019 Aug; 234(10):17912-17924. PubMed ID: 30834525
[TBL] [Abstract][Full Text] [Related]
20. Pre-treatment with angiotensin-(1-7) inhibits tumor growth via autophagy by downregulating PI3K/Akt/mTOR signaling in human nasopharyngeal carcinoma xenografts.
Lin YT; Wang HC; Chuang HC; Hsu YC; Yang MY; Chien CY
J Mol Med (Berl); 2018 Dec; 96(12):1407-1418. PubMed ID: 30374682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
